Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 301-325 of 1,000 matching filings.

Per page
25
Current page
13
UPLOAD

UPLOAD filing

Filing date
22 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-261185

S-1

Filing date
18 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-258816

RW

Filing date
18 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B/A File 001-11460

8-A12B

Filing date
18 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11460

CERT filing

Filing date
22 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11460

8-A12B

Filing date
22 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-11460

25

Filing date
22 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-260200

S-8

Filing date
12 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Sep 2021
Reporting date
20 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
22 Sep 2021
Reporting date
20 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42217

SC 13G filing

Filing date
27 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

DEFA14A

Filing date
20 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
20 Aug 2021
Reporting date
06 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .